SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-200435
Filing Date
2024-08-14
Accepted
2024-08-14 12:27:03
Documents
22
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d876011d8k.htm   iXBRL 8-K 50855
2 EX-1.1 d876011dex11.htm EX-1.1 262177
3 EX-4.3 d876011dex43.htm EX-4.3 188669
4 EX-5.1 d876011dex51.htm EX-5.1 14644
5 EX-5.2 d876011dex52.htm EX-5.2 11608
10 GRAPHIC g876011dsp06.jpg GRAPHIC 3999
11 GRAPHIC g876011dsp07.jpg GRAPHIC 2386
12 GRAPHIC g876011dsp09.jpg GRAPHIC 2255
13 GRAPHIC g876011g0813114520716.jpg GRAPHIC 2723
  Complete submission text file 0001193125-24-200435.txt   867192

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lly-20240812.xsd EX-101.SCH 5929
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20240812_def.xml EX-101.DEF 16467
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20240812_lab.xml EX-101.LAB 28462
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20240812_pre.xml EX-101.PRE 17954
25 EXTRACTED XBRL INSTANCE DOCUMENT d876011d8k_htm.xml XML 15875
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 241205794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)